1. Liu RK, Li CH, Zou SJ. Reducing scar formation after lip repair by injecting botulinum toxin. Plast Reconstr Surg. 2010; 125:1573–1574.
Article
2. Wang L, Tai NZ, Fan ZH. Effect of botulinum toxin type A injection on hypertrophic scar in rabbit ear model. Zhonghua Zheng Xing Wai Ke Za Zhi. 2009; 25:284–287.
3. Kono T, Erçöçen AR, Nakazawa H, Nozaki M. Treatment of hypertrophic scars using a long-pulsed dye laser with cryogen-spray cooling. Ann Plast Surg. 2005; 54:487–493.
Article
4. Ryu HW, Cho JH, Lee KS, Cho JW. Prevention of thyroidectomy scars in Korean patients using a new combination of intralesional injection of low-dose steroid and pulsed dye laser starting within 4 weeks of suture removal. Dermatol Surg. 2014; 40:562–568.
Article
5. Kim DH, Ryu HJ, Choi JE, Ahn HH, Kye YC, Seo SH. A comparison of the scar prevention effect between carbon dioxide fractional laser and pulsed dye laser in surgical scars. Dermatol Surg. 2014; 40:973–978.
Article
6. Son IP, Park KY, Kim B, Kim MN. Pilot study of the efficacy of 578 nm copper bromide laser combined with intralesional corticosteroid injection for treatment of keloids and hypertrophic scars. Ann Dermatol. 2014; 26:156–161.
Article
7. Shaarawy E, Hegazy RA, Abdel Hay RM. Intralesional botulinum toxin type A equally effective and better tolerated than intralesional steroid in the treatment of keloids: a randomized controlled trial. J Cosmet Dermatol. 2015; 14:161–166.
Article
8. Chen M, Yan T, Ma K, Lai L, Liu C, Liang L, et al. Botulinum toxin type A inhibits α-smooth muscle actin and myosin II expression in fibroblasts derived from scar contracture. Ann Plast Surg. 2014; DOI:
10.1097/SAP.0000-000000000268. [Epub ahead of print].
Article
9. Xiaoxue W, Xi C, Zhibo X. Effects of botulinum toxin type A on expression of genes in keloid fibroblasts. Aesthet Surg J. 2014; 34:154–159.
Article